As of 2026-10-02, the EV/EBITDA ratio of Homology Medicines Inc (FIXX) is 0.09. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FIXX's latest enterprise value is -8.12 mil USD. FIXX's TTM EBITDA according to its financial statements is -92.11 mil USD. Dividing these 2 quantities gives us the above FIXX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.4x - 16.0x | 15.6x |
| Forward P/E multiples | 17.3x - 19.7x | 18.5x |
| Fair Price | (671.06) - (620.03) | (663.68) |
| Upside | -5078.0% - -4699.5% | -5023.3% |
| Date | EV/EBITDA |
| 2026-09-30 | 0.10 |
| 2026-09-29 | 0.10 |
| 2026-09-28 | 0.10 |
| 2026-09-25 | 0.10 |
| 2026-09-24 | 0.10 |
| 2026-09-23 | 0.11 |
| 2026-09-22 | 0.11 |
| 2026-09-21 | 0.11 |
| 2026-09-18 | 0.10 |
| 2026-09-17 | 0.13 |
| 2026-09-16 | 0.12 |
| 2026-09-15 | 0.13 |
| 2026-09-14 | 0.12 |
| 2026-09-11 | 0.08 |
| 2026-09-10 | 0.12 |
| 2026-09-09 | 0.11 |
| 2026-09-08 | 0.10 |
| 2026-09-04 | 0.11 |
| 2026-09-03 | 0.12 |
| 2026-09-02 | 0.13 |
| 2026-09-01 | 0.13 |
| 2026-08-31 | 0.13 |
| 2026-08-28 | 0.14 |
| 2026-08-27 | 0.11 |
| 2026-08-26 | 0.10 |
| 2026-08-25 | 0.12 |
| 2026-08-24 | 0.11 |
| 2026-08-21 | 0.09 |
| 2026-08-20 | 0.08 |
| 2026-08-19 | 0.07 |